peritoneal dialysis

Summary

Summary: Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure.

Top Publications

  1. ncbi Morphologic changes in the peritoneal membrane of patients with renal disease
    John D Williams
    Institute of Nephrology, University of Wales College of Medicine, Cardiff, United Kingdom
    J Am Soc Nephrol 13:470-9. 2002
  2. pmc Global trends in rates of peritoneal dialysis
    Arsh K Jain
    Division of Nephrology, University of Western Ontario, London, Canada
    J Am Soc Nephrol 23:533-44. 2012
  3. ncbi The pathophysiology of the peritoneal membrane
    Olivier Devuyst
    Division of Nephrology, UCL Medical School, 10 Avenue Hippocrate, B 1200 Brussels, Belgium
    J Am Soc Nephrol 21:1077-85. 2010
  4. ncbi Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions
    Luiz S Aroeira
    Unidad de Biologia Molecular, Hospital Universitario de la Princesa, C Diego de Leon 62, Madrid, Spain
    J Am Soc Nephrol 18:2004-13. 2007
  5. ncbi Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure
    Manuel López-Cabrera
    Unidad de Biologia Molecular, Hospital Universitario de la Princesa, Diego de Leon, 62, 28006 Madrid, Spain
    Perit Dial Int 26:26-34. 2006
  6. ncbi Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis
    Jwa Kyung Kim
    Department of Internal Medicine and Kidney Research Institute, Hallym University College of Medicine, Anyang, Republic of Korea
    Atherosclerosis 220:208-14. 2012
  7. ncbi Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations
    Stephen P McDonald
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    J Am Soc Nephrol 14:2894-901. 2003
  8. ncbi Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States
    Austin G Stack
    Division of Renal Diseases and Hypertension, Department of Internal Medicine, University of Texas Health Sciences Center at Houston, Houston, Texas, USA
    Kidney Int 64:1071-9. 2003
  9. pmc Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort
    Wim Van Biesen
    University Hospital Ghent, Ghent, Belgium
    PLoS ONE 6:e17148. 2011
  10. pmc Impact of individual and environmental socioeconomic status on peritoneal dialysis outcomes: a retrospective multicenter cohort study
    Rong Xu
    Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health, Key Laboratory of Renal Disease, Ministry of Education, Beijing, China
    PLoS ONE 7:e50766. 2012

Detail Information

Publications340 found, 100 shown here

  1. ncbi Morphologic changes in the peritoneal membrane of patients with renal disease
    John D Williams
    Institute of Nephrology, University of Wales College of Medicine, Cardiff, United Kingdom
    J Am Soc Nephrol 13:470-9. 2002
    This study examined the morphologic features of the parietal peritoneal membranes of 130 patients undergoing peritoneal dialysis (PD) and compared them with the features of the peritoneal membranes of normal individuals, uremic ..
  2. pmc Global trends in rates of peritoneal dialysis
    Arsh K Jain
    Division of Nephrology, University of Western Ontario, London, Canada
    J Am Soc Nephrol 23:533-44. 2012
    Although there is a perception that the use of peritoneal dialysis is declining worldwide, compilations of global data are unavailable to test this hypothesis...
  3. ncbi The pathophysiology of the peritoneal membrane
    Olivier Devuyst
    Division of Nephrology, UCL Medical School, 10 Avenue Hippocrate, B 1200 Brussels, Belgium
    J Am Soc Nephrol 21:1077-85. 2010
    The development of peritoneal dialysis (PD) as a successful therapy has and still depends on experimental models to test and understand critical pieces of pathophysiology...
  4. ncbi Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions
    Luiz S Aroeira
    Unidad de Biologia Molecular, Hospital Universitario de la Princesa, C Diego de Leon 62, Madrid, Spain
    J Am Soc Nephrol 18:2004-13. 2007
    b>Peritoneal dialysis (PD) is a form of renal replacement and is based on the use of the peritoneum as a semipermeable membrane across which ultrafiltration and diffusion take place...
  5. ncbi Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure
    Manuel López-Cabrera
    Unidad de Biologia Molecular, Hospital Universitario de la Princesa, Diego de Leon, 62, 28006 Madrid, Spain
    Perit Dial Int 26:26-34. 2006
    During peritoneal dialysis (PD), the peritoneum is exposed to bioincompatible dialysis fluids, which causes progressive fibrosis and angiogenesis and, ultimately, ultrafiltration failure...
  6. ncbi Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis
    Jwa Kyung Kim
    Department of Internal Medicine and Kidney Research Institute, Hallym University College of Medicine, Anyang, Republic of Korea
    Atherosclerosis 220:208-14. 2012
    ..We determined the levels of sRAGE and EN-RAGE in peritoneal dialysis (PD) patients and evaluated their relationship with carotid atherosclerosis.
  7. ncbi Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations
    Stephen P McDonald
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    J Am Soc Nephrol 14:2894-901. 2003
    ..Whether this association holds true among patients treated with peritoneal dialysis (PD) has been less well studied...
  8. ncbi Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States
    Austin G Stack
    Division of Renal Diseases and Hypertension, Department of Internal Medicine, University of Texas Health Sciences Center at Houston, Houston, Texas, USA
    Kidney Int 64:1071-9. 2003
    It is hypothesized, but not proven, that peritoneal dialysis might be the optimal treatment for end-stage renal disease (ESRD) patients with established congestive heart failure (CHF) through better volume regulation compared with ..
  9. pmc Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort
    Wim Van Biesen
    University Hospital Ghent, Ghent, Belgium
    PLoS ONE 6:e17148. 2011
    Euvolemia is an important adequacy parameter in peritoneal dialysis (PD) patients...
  10. pmc Impact of individual and environmental socioeconomic status on peritoneal dialysis outcomes: a retrospective multicenter cohort study
    Rong Xu
    Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health, Key Laboratory of Renal Disease, Ministry of Education, Beijing, China
    PLoS ONE 7:e50766. 2012
    We aimed to explore the impacts of individual and environmental socioeconomic status (SES) on the outcome of peritoneal dialysis (PD) in regions with significant SES disparity, through a retrospective multicenter cohort in China.
  11. ncbi Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis
    Chih Hung Guo
    Institute of Biomedical Nutrition, Hung Kuang University, Taichung 433, Taiwan, ROC
    Clin Biochem 44:275-80. 2011
    We evaluated the relationship of the plasma copper/zinc (Cu/Zn) ratio with nutritional status, inflammation, oxidative stress, and immune function in peritoneal dialysis patients.
  12. pmc HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium
    Min A Yu
    Division of Nephrology, Ewha University School of Medicine, YangChun Ku, Seoul, Korea
    J Am Soc Nephrol 20:567-81. 2009
    Over time, peritoneal dialysis results in functional and structural alterations of the peritoneal membrane, but the underlying mechanisms and whether these changes are reversible are not completely understood...
  13. ncbi The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis
    Edward F Vonesh
    Baxter Healthcare Corporation, Applied Statistics Center, Round Lake, Illinois 60073, USA
    Kidney Int 66:2389-401. 2004
    ..Trends in available data indicate the relative risk of death with hemodialysis (HD) compared to peritoneal dialysis (PD) varies by time on dialysis and the presence of various risk factors...
  14. ncbi Predictors of the rate of decline of residual renal function in incident dialysis patients
    Maarten A M Jansen
    Division of Nephrology, Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Kidney Int 62:1046-53. 2002
    ..Few studies have been published on risk factors for loss of RRF in dialysis patients. These studies were either retrospective, performed in a small number of patients, or estimated GFR without a urine collection...
  15. ncbi Peritoneal dialysis-related infections recommendations: 2010 update
    Philip Kam Tao Li
    Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong
    Perit Dial Int 30:393-423. 2010
  16. ncbi Predictors of loss of residual renal function among new dialysis patients
    L M Moist
    Department of Medicine, University of Western Ontario, London, Canada
    J Am Soc Nephrol 11:556-64. 2000
    ..to determine the predictors of RRF loss in a national random sample of patients initiating hemodialysis and peritoneal dialysis. The study controlled for baseline variables and included major predictors...
  17. ncbi Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis
    Chia Te Liao
    Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
    Nephrol Dial Transplant 24:2909-14. 2009
    Residual renal function (RRF) at the initiation of peritoneal dialysis (PD) therapy can predict patient outcome. However, RRF declines with time at variable rates in different patients...
  18. ncbi Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms
    Bert Bammens
    Department of Medicine, Division of Nephrology and Laboratory of Radiopharmaceutical Chemistry, University Hospital Gasthuisberg, Leuven, Belgium
    Kidney Int 64:2238-43. 2003
    Current guidelines for peritoneal dialysis adequacy are based on kinetics of small water-soluble molecules and do not consider the role of other compounds such as middle molecules and protein-bound solutes...
  19. ncbi An update on peritoneal dialysis solutions
    Elvia Garcia-Lopez
    Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, K56 Karolinska University Hospital Huddinge, S 141 86 Stockholm, Sweden
    Nat Rev Nephrol 8:224-33. 2012
    b>Peritoneal dialysis (PD) has achieved its current position as the most commonly used home-based dialysis therapy--and with patient survival equal to that seen with hemodialysis--despite the use of glucose-based dialysis solutions with ..
  20. ncbi Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor
    Luiz S Aroeira
    Servicio de Nefrologia, Hospital Universitario de la Princesa, Madrid, Spain
    Am J Kidney Dis 46:938-48. 2005
    During peritoneal dialysis (PD), the peritoneum is exposed to bioincompatible dialysis fluids that cause epithelial-to-mesenchymal transition of mesothelial cells, fibrosis, and angiogenesis...
  21. pmc Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis
    Ruth M Tarzi
    Imperial College Kidney and Transplant Institute, Hammersmith Hospital, London, UK
    Clin J Am Soc Nephrol 3:1702-10. 2008
    Encapsulating peritoneal sclerosis (EPS) is a severe peritoneal fibrotic reaction in patients on long-term peritoneal dialysis (PD). The early clinical features may be nonspecific...
  22. pmc Encapsulating peritoneal sclerosis in the new millennium: a national cohort study
    Michaela C Brown
    Scottish Renal Registry, Royal Infirmary, Glasgow, UK
    Clin J Am Soc Nephrol 4:1222-9. 2009
    The study aim was to establish the incidence and characterize all encapsulating peritoneal sclerosis (EPS) cases in patients treated by peritoneal dialysis (PD).
  23. pmc Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage
    Jesus Loureiro
    Unidad de Biología Molecular and Servicio de Nefrología, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    J Am Soc Nephrol 22:1682-95. 2011
    During peritoneal dialysis (PD), mesothelial cells undergo mesothelial-to-mesenchymal transition (MMT), a process associated with peritoneal-membrane dysfunction...
  24. ncbi Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients
    L Fried
    Renal Section, VA Pittsburgh Healthcare System, and Renal Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Am J Kidney Dis 37:337-42. 2001
    ..The purpose of this study was to examine the usefulness of the CCI as a predictor in incident peritoneal dialysis (PD) patients and to examine whether it was a better predictor than simply the number of comorbid ..
  25. ncbi Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients
    Meltem Sezis Demirci
    Division of Nephrology, Ege University School of Medicine, Izmir, Turkey
    Nephrol Dial Transplant 26:1708-16. 2011
    Chronic fluid overload (FO) is frequently present in peritoneal dialysis (PD) patients and is associated with hypertension and left ventricular hypertrophy and dysfunction, which are important predictors of death in dialysis patients...
  26. ncbi Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients
    Chia Te Liao
    Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
    Perit Dial Int 28:S191-5. 2008
    Loss of residual renal function (RRF) in peritoneal dialysis (PD) patients is a powerful predictor of mortality. The present study was conducted to determine the predictors of faster decline of RRF in PD patients in Taiwan.
  27. ncbi Recurrent and atypical posterior reversible encephalopathy syndrome in a child with peritoneal dialysis
    Ilknur Girişgen
    Department of Pediatrics, Adnan Menderes University Faculty of Medicine, Aydm, Turkey
    Turk J Pediatr 52:416-9. 2010
    ..this article, we present recurrent atypical PRES in a hypertensive child with end-stage renal disease on a peritoneal dialysis program as a rare case and we discuss recurrence...
  28. ncbi Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data
    David W Johnson
    Australia and New Zealand Dialysis and Transplant Registry, Discipline of Public Health, University of Adelaide, Adelaide, Australia
    Nephrol Dial Transplant 24:1598-603. 2009
    ..The aim of the present investigation was to evaluate the rates of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections in peritoneal dialysis (PD) and haemodialysis (HD) patients in the Asia-Pacific region.
  29. pmc Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients
    Edwina A Brown
    Imperial College Kidney and Transplant Institute, Hammersmith Hospital, London, UK
    Nephrol Dial Transplant 25:3755-63. 2010
    ..Little is, however, known about differences in QOL on haemodialysis (HD) and peritoneal dialysis (PD) in older age groups. Randomising patients to either modality to assess outcomes is not feasible.
  30. ncbi Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients
    Isabel Devolder
    Renal Division, University Hospital Ghent, Ghent, Belgium
    Perit Dial Int 30:208-14. 2010
    ..A new multifrequency bioimpedance tool has recently been validated. This study compares volume status in peritoneal dialysis (PD) and hemodialysis (HD) patients in a single center.
  31. pmc Functional effector memory T cells enrich the peritoneal cavity of patients treated with peritoneal dialysis
    Gareth W Roberts
    Institute of Nephrology, School of Medicine, Cardiff University, Heath Park, Cardiff, Wales, UK
    J Am Soc Nephrol 20:1895-900. 2009
    ..peritonitis adversely affect the structure and function of the peritoneal membrane in patients treated with peritoneal dialysis (PD), but the underlying mechanisms are not well understood...
  32. ncbi The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients
    Meltem Sezis Demirci
    Division of Nephrology, Ege University School of Medicine, Izmir, Turkey
    Perit Dial Int 29:S15-7. 2009
    One of the origins of cardiovascular disease in dialysis patients is arterial stiffness. The aim of our study was to assess the relationship between the calcium content of peritoneal dialysis (PD) solution and arterial stiffness.
  33. ncbi Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients
    Angela Yee Moon Wang
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Nephrol Dial Transplant 20:1676-85. 2005
    ..However, its relationships with cardiac valvular calcification and atherosclerosis and outcome have not been evaluated in peritoneal dialysis (PD) patients.
  34. pmc Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 21:499-506. 2010
    Contemporary comparisons of mortality in matched hemodialysis and peritoneal dialysis patients are lacking...
  35. ncbi Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study
    J M Bargman
    Division of Nephrology, Toronto General Hospital, University of Toronto, 200 Elizabeth Street EN10 216, Toronto, Ontario M5G 2C4, Canada
    J Am Soc Nephrol 12:2158-62. 2001
    Studies of the adequacy of peritoneal dialysis and recommendations have assumed that renal and peritoneal clearances are comparable and therefore additive. The CANUSA data were reanalyzed in an effort to address this assumption...
  36. ncbi Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?
    K A Herzig
    Department of Renal Medicine, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane Q 4102, Australia
    J Am Soc Nephrol 12:814-21. 2001
    ..However, its predictive value in peritoneal dialysis (PD) patients has not been assessed...
  37. ncbi Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam
    Nguyen Hoan Phu
    Center for Tropical Diseases, Center for Tropical Diseases, Cho Quan Hospital, Ho Chi Minh City, Vietnam
    N Engl J Med 347:895-902. 2002
    In some parts of the world, peritoneal dialysis is widely used for renal replacement in acute renal failure...
  38. pmc Relationship between dialysis modality and mortality
    Stephen P McDonald
    Renal Unit, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville South SA 5011, Australia
    J Am Soc Nephrol 20:155-63. 2009
    Mortality differences between peritoneal dialysis (PD) and hemodialysis (HD) are widely debated...
  39. ncbi Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2
    Fabian Termorshuizen
    Departments of Clinical Epidemiology and Biostatistics and Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Am Soc Nephrol 14:2851-60. 2003
    Various studies indicate that fair comparisons of mortality rates between hemodialysis (HD) patients and peritoneal dialysis (PD) patients are difficult because of differences in patient characteristics, because of nonconstant relative ..
  40. ncbi Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan
    Chiu Ching Huang
    Department of Medicine and Biostatistics Center, China Medical University, Taiwan
    Perit Dial Int 28:S15-20. 2008
    Comparisons of survival in patients on peritoneal dialysis (PD) and on hemodialysis (HD) have been conducted in many Western countries, but publications on this subject in Asian populations are scarce...
  41. pmc Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis
    Rajnish Mehrotra
    Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor UCLA, Torrance, CA, USA
    Am J Kidney Dis 58:418-28. 2011
    ..Whether the threshold level of serum albumin at which mortality risk increases in peritoneal dialysis (PD) patients is the same as for hemodialysis (HD) patients has not been studied.
  42. ncbi Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease
    Rajnish Mehrotra
    Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90502, USA
    Arch Intern Med 171:110-8. 2011
    The annual payer costs for patients treated with peritoneal dialysis (PD) are lower than with hemodialysis (HD), but in 2007, only 7% of dialysis patients in the United States were treated with PD...
  43. ncbi Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease
    Bernard G Jaar
    Johns Hopkins University School of Medicine, Johns Hopkins Bloomberg School of Public Health, and Independent Dialysis Foundation, Baltimore, Maryland 21205, USA
    Ann Intern Med 143:174-83. 2005
    ..The influence of type of dialysis on survival of patients with end-stage renal disease (ESRD) is controversial...
  44. ncbi Basic mechanisms and clinical implications of peritoneal fibrosis
    Peter J Margetts
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Perit Dial Int 23:530-41. 2003
    ..Clinical trials to assess the role of prevention of peritoneal injury using biocompatible solutions and treatments targeted directly at peritoneal fibrosis will be important, but challenging to design and carry out...
  45. ncbi Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment
    Hidetomo Nakamoto
    Department of Nephrology, Tokorozawa Kidney Clinic, Tokorozawa, Japan
    Perit Dial Int 25:S30-8. 2005
    Encapsulating peritoneal sclerosis (EPS) is recognized as a serious complication of continuous peritoneal dialysis. A preliminary diagnosis of EPSis usually based on clinical signs and symptoms, which commonly include abdominal pain, ..
  46. ncbi PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage
    Pilar Sandoval
    Unidad de Biologia Molecular, Hospital Universitario de la Princesa, Madrid, Spain
    Lab Invest 90:1517-32. 2010
    Exposure to non-physiological solutions during peritoneal dialysis (PD) produces structural alterations to the peritoneal membrane and ultrafiltration dysfunction...
  47. ncbi Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003
    Andrew Davenport
    UCL Centre for Nephrology, Royal Free and University College Medical School, London, United Kingdom
    Perit Dial Int 29:297-302. 2009
    Over the past two decades, the rate of peritonitis in patients treated by peritoneal dialysis (PD) has been significantly reduced...
  48. ncbi Encapsulating peritoneal sclerosis: clinical significance and implications
    T Augustine
    Manchester Institute of Nephrology and Transplantation, Manchester Royal Infirmary, Manchester, UK
    Nephron Clin Pract 111:c149-54; discussion c154. 2009
    Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of peritoneal dialysis (PD)...
  49. ncbi Extracellular water/intracellular water is a strong predictor of patient survival in incident peritoneal dialysis patients
    Wei Chen
    Division of Nephrology, Peking University Third Hospital, Beijing, PR China
    Blood Purif 25:260-6. 2007
    The mortality rate of peritoneal dialysis (PD) patients is still high and controversies persist regarding the mortality predictor...
  50. ncbi Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis
    Thomas A Golper
    Vanderbilt University, Nashville, TN 37232, USA
    Am J Kidney Dis 58:879-85. 2011
    ..Identification and recognition of such barriers is the first step. In addition, we have suggested action plans to stimulate the kidney community to find even better solutions so that collectively we may overcome these barriers...
  51. ncbi Ossification of the peritoneal membrane
    Nicola Di Paolo
    Department of Nephrology and Dialysis, University Hospital, Siena, Italy
    Perit Dial Int 24:471-7. 2004
    b>Peritoneal dialysis (PD) patients rarely develop sclerosing peritonitis (SP), a severe, life-threatening condition of unknown pathogenesis...
  52. ncbi Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes
    Suchai Sritippayawan
    Division of Nephrology, Department of Internal Medicine, Medical Molecular Biology Unit, Office for Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
    J Proteome Res 6:4356-62. 2007
    Efficacy of peritoneal dialysis is determined by solute transport through peritoneal membranes...
  53. ncbi Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients
    J Y Yeun
    Department of Medicine, University of California Davis, Sacramento 95817, USA
    Am J Kidney Dis 30:923-7. 1997
    ..To establish the cause of hypoalbuminemia in a group of 27 patients on peritoneal dialysis (PD), we determined the relationship between serum albumin concentration and a group of parameters ..
  54. ncbi Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients
    W S An
    Department of Internal Medicine, Dong A University, Busan, Republic of Korea
    J Ren Nutr 19:267-74. 2009
    ..Given the impact of ethnic and dietary factors, we sought to examine membrane fatty acid composition in an ethnically homogeneous end-stage renal disease population residing in a coastal region of Korea with high fish consumption...
  55. ncbi Application of body composition monitoring to peritoneal dialysis patients
    Carlo Crepaldi
    Department of Nephrology, St Bortolo Hospital, Vicenza, Italy
    Contrib Nephrol 163:1-6. 2009
    Assessment of body fluids in peritoneal dialysis is an important issue in the treatment of renal failure...
  56. ncbi Body size and outcomes on peritoneal dialysis in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 64:1838-44. 2003
    Being overweight is often cited as a relative contraindication to peritoneal dialysis. Our primary objective was to determine whether actual mortality rates support this opinion.
  57. ncbi Peritoneal dialysis versus hemodialysis: risks, benefits, and access issues
    Ramapriya Sinnakirouchenan
    Department of Internal Medicine, University of Illinois, Urbana Champaign, USA
    Adv Chronic Kidney Dis 18:428-32. 2011
    b>Peritoneal dialysis (PD) and hemodialysis (HD) are dialysis options for end-stage renal disease patients in whom preemptive kidney transplantation is not possible...
  58. ncbi Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada
    Karen Yeates
    Department of Medicine, Queen s University, Kingston, Ontario, Canada
    Nephrol Dial Transplant 27:3568-75. 2012
    ..0% of patients on peritoneal dialysis (PD) and 48.9% on hemodialysis (HD) and a remaining 40.1% living with a functioning kidney transplant...
  59. ncbi Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study
    Xiao Yang
    Department of Nephrology, The First Affiliated Hospital, Sun Yat Sen University, Guangzhou 510080, China
    Diabetes Res Clin Pract 100:354-61. 2013
    We evaluated clinical outcome and risk factors affecting survival in patients with diabetes on continuous ambulatory peritoneal dialysis (CAPD) in Southern China.
  60. ncbi Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States
    Shuling Li
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 65:1864-9. 2004
    The view that hemoglobin levels in peritoneal dialysis patients should be maintained at 11 to 12 g/dL is based largely on the results of studies in hemodialysis patients.
  61. ncbi Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes
    Katherine Barraclough
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    Am J Kidney Dis 55:121-31. 2010
    The study aim was to examine the frequency, predictors, treatment, and clinical outcomes of peritoneal dialysis-associated polymicrobial peritonitis.
  62. ncbi Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease
    Santhi K Ganesh
    Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA
    J Am Soc Nephrol 14:415-24. 2003
    It is unclear whether peritoneal dialysis (PD) compared with hemodialysis (HD) confers a survival advantage in end-stage renal disease (ESRD) patients with coronary artery disease (CAD)...
  63. ncbi Hemoglobin variability in patients with chronic kidney disease in the Netherlands
    Karien van der Putten
    Department of Internal Medicine, Meander Medical Center, Amersfoort the Netherlands
    Int J Artif Organs 32:787-93. 2009
    ..Information on hemoglobin cycling in Europe is limited. We investigated hemoglobin variability in the Netherlands. Hemodialysis and peritoneal dialysis patients were studied and pre-dialysis patients were enrolled.
  64. ncbi Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study
    Mario R Korte
    Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands
    Nephrol Dial Transplant 26:691-7. 2011
    Encapsulating peritoneal sclerosis (EPS) is a serious complication of peritoneal dialysis (PD) with an increasing incidence...
  65. ncbi Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysis
    Chih Hung Guo
    Institute of Biomedical Nutrition, Hung Kuang University, Taichung, Taiwan, Republic of China
    Perit Dial Int 31:583-91. 2011
    ..trace elements may affect the inflammatory and immunological state of patients on hemodialysis (HD) or peritoneal dialysis (PD)...
  66. ncbi Nutrition in patients on peritoneal dialysis
    Seung Hyeok Han
    Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei ro Seodaemun gu, Seoul 120 752, Korea
    Nat Rev Nephrol 8:163-75. 2012
    ..The causes and clinical features of PEW in patients on peritoneal dialysis and hemodialysis are comparable; assessment of the factors that lead to PEW in patients receiving ..
  67. ncbi Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study
    Marianne Haag-Weber
    St Elisabeth Krankenhaus, Straubing, Germany
    Nephrol Dial Transplant 25:2288-96. 2010
    Residual renal function (RRF) impacts outcome of peritoneal dialysis (PD) patients. Some PD fluids contain glucose degradation products (GDPs) which have been shown to affect cell systems and tissues...
  68. ncbi Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes
    David W Johnson
    Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia
    Kidney Int 77:904-12. 2010
    Encapsulating peritoneal sclerosis is a complication of peritoneal dialysis characterized by persistent, intermittent, or recurrent adhesive bowel obstruction...
  69. ncbi Effect of fluid and sodium removal on mortality in peritoneal dialysis patients
    K Ates
    Ankara University Medical School, Ibn i Sina Hospital, Department of Nephrology, Ankara, Turkey
    Kidney Int 60:767-76. 2001
    Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.
  70. ncbi Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients
    Nirav Shah
    Renal Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    Perit Dial Int 25:362-6. 2005
    b>Peritoneal dialysis (PD) patients are at risk for 25(OH) vitamin D deficiency due to effluent loss in addition to traditional risk factors.
  71. ncbi Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation
    E Boulanger
    Vascular and Cellular Biology Laboratory, Institut National de la Transfusion Sanguine, University of Paris7 Denis Diderot, Paris, France
    Kidney Int 71:126-33. 2007
    ..AGEs) inhibit ischemia-induced angiogenesis but are potential triggers of neoangiogenesis that occurs in peritoneal dialysis (PD) patients...
  72. pmc Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients
    Luis C Martin
    Department of Internal Medicine, Botucatu Medical School, 18618 000 Botucatu, Sao Paulo, Brazil
    Clin J Am Soc Nephrol 6:1944-51. 2011
    Peritonitis remains as the most frequent cause of peritoneal dialysis (PD) failure, impairing patient's outcome...
  73. ncbi Peritoneal dialysis-associated peritonitis in Scotland (1999-2002)
    David Kavanagh
    The Scottish Renal Registry, Royal Infirmary, Castle Street, Glasgow G4 0SF, UK
    Nephrol Dial Transplant 19:2584-91. 2004
    Peritonitis is a major complication of peritoneal dialysis (PD). We have performed a national study of all patients on PD in Scotland over a 3...
  74. ncbi Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre
    Sung Hee Chung
    Hyonam Kidney Laboratory, Soon Chun Hyang University, 657 Hannam Dong, Yongsan Ku, Seoul 140 743, Korea
    Nephrol Dial Transplant 20:1207-13. 2005
    Dialysis patient mortality remains high, and this high mortality may be due to many factors. In peritoneal dialysis (PD) patients, old age, co-morbid diseases, malnutrition, low residual renal function (RRF) and a high peritoneal ..
  75. ncbi Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis
    Hon Yen Wu
    Department of Internal Medicine, Yun Lin branch, National Taiwan University Hospital, Yun Lin, Taiwan
    Am J Nephrol 28:765-71. 2008
    A high glucose content in peritoneal dialysis (PD) solution may result in unfavorable changes on peritoneal character and worsened metabolic profiles...
  76. ncbi Cardiovascular problems in dialysis patients: impact on survival
    Manavjot S Sidhu
    Department of Internal Medicine, University of Missouri, Columbia, Missouri 65212, USA
    Adv Perit Dial 26:47-52. 2010
    ..from clinical trials, data from randomized controlled trials regarding outcomes in patients undergoing peritoneal dialysis are almost absent...
  77. pmc Cancer in patients on chronic dialysis in Korea
    Jung Eun Lee
    Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    J Korean Med Sci 24:S95-S101. 2009
    ..3%) out of 4,562 end-stage renal disease (ESRD) patients maintained on hemodialysis (HD) or peritoneal dialysis (PD) at Yonsei University Health System from 1996 to 2005...
  78. pmc Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum
    Peter J Margetts
    Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
    Am J Pathol 160:2285-94. 2002
    Peritonitis, a common complication of peritoneal dialysis, is followed by acute changes in the function of the peritoneum. The role of inflammatory cytokines in these processes is not clearly identified...
  79. ncbi Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA
    Wai H Lim
    Renal Unit, Queen Elizabeth Hospital, Adelaide, South Australia, Australia
    Nephrology (Carlton) 10:192-7. 2005
    Aboriginal patients maintained on peritoneal dialysis (PD) have a higher rate of technique failure than any other racial group in Australia...
  80. ncbi Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis
    Hideki Yokoi
    Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Kidney Int 81:160-9. 2012
    Long-term peritoneal dialysis induces peritoneal fibrosis with submesothelial fibrotic tissue. Although angiogenesis and inflammatory mediators are involved in peritoneal fibrosis, precise molecular mechanisms are undefined...
  81. ncbi Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients
    Dominik M Alscher
    Department of Internal Medicine, Division of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany
    Am J Kidney Dis 49:452-61. 2007
    ..that increased mast cell numbers contribute substantially to the fibrosis often seen in the peritoneum of peritoneal dialysis (PD) patients, particularly those with encapsulating peritoneal fibrosis (EPS)...
  82. ncbi Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells
    Sonja Mandl-Weber
    Nephrologisches Zentrum, Medizinische Klinik und Poliklinik Innenstadt, Klinikum der Universitat Munchen, Munich, Germany
    Kidney Int 61:570-8. 2002
    Vascular endothelial growth factor (VEGF) was recently found in peritoneal effluents of peritoneal dialysis (PD) patients...
  83. ncbi Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis
    H Taskapan
    Inonu University Medical School, Department of Medicine, Division of Nephrology, Malatya, Turkey
    Clin Nephrol 66:247-55. 2006
    The aim of this study was to evaluate the prevalence of vitamin D deficiency in chronic renal failure (CRF) patients on peritoneal dialysis (PD) and to correlate the findings with various demographic and renal osteodystrophy markers.
  84. ncbi The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions
    Qiang Yao
    Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Karolinska Institutet, Stockholm, Sweden
    Nephron Exp Nephrol 109:e71-8. 2008
    b>Peritoneal dialysis (PD) solutions contribute to peritoneal membrane damage...
  85. ncbi The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis
    Devrim Bozkurt
    Department of Nephrology, Ege University, Izmir, Turkey
    Perit Dial Int 28:S38-42. 2008
    ..b>Peritoneal dialysis (PD) patients rarely develop EPS, a severe life-threatening condition of unknown pathogenesis...
  86. ncbi Peritoneal changes after exposure to sterile solutions by catheter
    Michael F Flessner
    Division of Nephrology, Department of Medicine, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216 4505, USA
    J Am Soc Nephrol 18:2294-302. 2007
    ..These findings confirm the hypothesis that the presence of a PC catheter increases inflammatory response to sterile solutions as evidenced by the structural and functional changes in the peritoneal barrier...
  87. ncbi Mesothelial cells
    Susan Yung
    Department of Medicine, University of Hong Kong, Hong Kong SAR, PR China
    Perit Dial Int 27:S110-5. 2007
    The introduction of peritoneal dialysis (PD) as a modality of renal replacement therapy has provoked much interest in the biology of the peritoneal mesothelial cell...
  88. ncbi Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease
    Ariel Berger
    Policy Analysis, Inc, Four Davis Ct, Brookline, MA 02445, USA
    Am J Manag Care 15:509-18. 2009
    To compare healthcare utilization and costs in patients with end-stage renal disease (ESRD) beginning peritoneal dialysis (PD) or hemodialysis (HD).
  89. ncbi Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass
    P Stenvinkel
    Division of Renal Medicine, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
    J Am Soc Nephrol 11:1303-9. 2000
    ..elevated leptin levels have been documented in uremic patients, especially in those who are treated by peritoneal dialysis (PD)...
  90. ncbi Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis
    J Ni
    Division of Nephrology and Department of Pathology, UCL Medical School, Brussels, Belgium
    Kidney Int 69:1518-25. 2006
    ..of the implication of AQP1 in solute-free water transport, sodium sieving, and ultrafiltration (UF) during peritoneal dialysis (PD) is lacking, and the effects of its deletion on the structure of the membrane are unknown...
  91. ncbi Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels
    Gloria A Preston
    Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Nephron 92:817-23. 2002
    Patients on chronic hemodialysis or peritoneal dialysis often develop an inflammatory state that causes morbidity and mortality...
  92. ncbi Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients
    Inna Kolesnyk
    Division of Nephrology, Academic Medical Center, Amsterdam, The Netherlands
    Perit Dial Int 27:446-53. 2007
    Long-term peritoneal dialysis (PD) may lead to peritoneal fibrosis and ultrafiltration failure. The latter occurs due to high solute transport rates and diabetiform peritoneal sclerosis...
  93. ncbi Sodium removal in patients undergoing CAPD and automated peritoneal dialysis
    Ana Rodriguez-Carmona
    Division of Nephrology, Hospital Juan Canalejo, A Coruna, Spain
    Perit Dial Int 22:705-13. 2002
    To compare sodium removal in continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) patients, and to identify the main factors that modify Na removal in clinical practice in these patients.
  94. ncbi Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study
    Constantijn J A M Konings
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    Kidney Int 63:1556-63. 2003
    Overhydration is a risk factor for hypertension and left ventricular hypertrophy in peritoneal dialysis patients. Recently, a high prevalence of subclinical overhydration was observed in peritoneal dialysis patients...
  95. ncbi Epidemiology of encapsulating peritoneal sclerosis in Japan
    Hideki Kawanishi
    Akane Foundation, Tsuchiya General Hospital, Hiroshima, Japan
    Perit Dial Int 25:S14-8. 2005
    Since the first peritoneal dialysis (PD) patients with encapsulating peritoneal sclerosis (EPS) were reported in 1980, EPS has been considered primarily a fatal complication...
  96. ncbi Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study
    Anniek Vlijm
    Department of Medicine, University of Amsterdam, Amsterdam, The Netherlands
    Perit Dial Int 29:517-22. 2009
    ..To establish CT findings characteristic for EPS, we compared CT findings between EPS patients and long-term peritoneal dialysis (PD) patients without EPS.
  97. pmc Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus
    Uyen Duong
    Harold Simmons Center for Chronic Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, California 90509 2910, USA
    Clin J Am Soc Nephrol 6:1041-8. 2011
    The optimal target for glycemic control has not been established for diabetic peritoneal dialysis (PD) patients.
  98. ncbi Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis
    Edward A Ross
    Division of Nephrology, Hypertension, and Transplantation, University of Florida, Gainesville, FL 32610 0224, USA
    Am J Nephrol 28:97-106. 2008
    ..This study investigates the effects of oral paricalcitol to reduce PTH in patients receiving chronic HD and peritoneal dialysis (PD).
  99. ncbi NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients
    Ramon Paniagua
    Unidad de Investigacion Medica en Enfermedades Nefrologicas, Hospital de Especialidades, CMN Siglo XXI, Mexico City
    Nephrol Dial Transplant 25:551-7. 2010
    ..It has been suggested that continuous ambulatory peritoneal dialysis (CAPD), automated peritoneal dialysis (APD) and haemodialysis (HD) may have different effects on fluid ..
  100. ncbi Cardiovascular risk in the peritoneal dialysis patient
    Raymond T Krediet
    Division of Nephrology, Department of Medicine, Academic Medical Centre University of Amsterdam, P O Box 22700, 1100 DE Amsterdam, The Netherlands
    Nat Rev Nephrol 6:451-60. 2010
    Cardiovascular death is the most frequent cause of death in patients on peritoneal dialysis. Risk factors for cardiovascular death in these patients include those that affect the general population as well as those related to end-stage ..
  101. ncbi Survival advantages of obesity in dialysis patients
    Kamyar Kalantar-Zadeh
    Division of Nephrology and Hypertension, Los Angeles Biomedical Institute at Harbor UCLA Medical Center, Torrance, CA 90509 2910, USA
    Am J Clin Nutr 81:543-54. 2005
    ..or dialysis-risk-paradox is relatively consistent in MHD patients, studies in CKD patients undergoing peritoneal dialysis have yielded mixed results...

Research Grants63

  1. An all titanium transcutaneous access device (TAD) for peritoneal dialysis
    Robert Whalen; Fiscal Year: 2007
    unreadable] DESCRIPTION (provided by applicant): Chronic transcutaneous access is needed for peritoneal dialysis (PD) and new emerging medical therapies...
  2. Conservative Versus Dialytic Management in Stage V Chronic Kidney Disease
    GLENN MATTHEW CHERTOW; Fiscal Year: 2010
    ..73m2. The dialytic intervention will include initiation of thrice weekly hemodialysis or conventional peritoneal dialysis following randomization...
  3. Comparative Effectiveness of Dialysis Modalities
    Rajnish Mehrotra; Fiscal Year: 2013
    ..The comparisons of these therapies with peritoneal dialysis and/or thrice-weekly conventional hemodialysis will be adequately powered for all-cause mortality, the ..
  4. Acute Renal Failure Mediated Lung Injury
    Sarah Faubel; Fiscal Year: 2013
    ..if the uremic factors that stimulate IL-6 production in AKI may be removed by dialysis, the effect of acute peritoneal dialysis on IL-6 production and serum IL-6 will be determined...
  5. Associations among RAAS Inhibitors, Residual Kidney Function, and CV Events in PD
    Jenny I Shen; Fiscal Year: 2013
    ..However, data on their effectiveness in patients undergoing peritoneal dialysis (PD) are limited...
  6. Regenerative Integration of Percutaneous Implants
    PHIL GORDON CAMPBELL; Fiscal Year: 2013
    DESCRIPTION (provided by applicant): Percutaneous medical devices such as central venous catheters, peritoneal dialysis catheters, and intraosseointegrated implants are ubiquitous in modern healthcare despite the fact that there is a ..
  7. Experience of Managing ESRD Dietary Modications
    MAYA NICOLE CLARK; Fiscal Year: 2011
    Hemodialysis, peritoneal dialysis, and kidney transplant are the only treatment options available for patients with end-stage renal disease (ESRD)...
  8. Anti-Infective Dermal Integration Sleeves for Needle Free Dialysis Access Devices
    Andrew Marshall; Fiscal Year: 2013
    ..Less expensive and more patient-friendly alternatives of home peritoneal dialysis (PD) and home hemodialysis (HHD) have not seen wide adoption, in part due to exit site infection risk (in ..
  9. Understanding Sources of Bias and Outcomes in Peritoneal Dialysis Patient Researc
    Kamyar Kalantar Zadeh; Fiscal Year: 2010
    ..by applicant): The proportion of individuals with advanced chronic kidney disease who undergo chronic peritoneal dialysis (CPD) treatment, currently <8% of the 400,000 dialysis patients in the USA, has been declining steadily ..
  10. Infections in Patients treated with Dialysis: Incidence, Risk Factors and Outcome
    Seth Wright; Fiscal Year: 2013
    ..understanding of the patterns and risks of infection in patients treated with maintenance hemodialysis and peritoneal dialysis. Infections are a major cause of mortality, morbidity, and health care utilization in the growing dialysis ..
  11. Unraveling the ultrafiltration rate--mortality association in dialysis patients
    Jennifer E Flythe; Fiscal Year: 2012
    ..Other untested methods of IDWG control including interdialytic peritoneal dialysis and wearable ultrafiltration devices do exist...
  12. The Production of Uremic Solutes by Colon Microbes
    Timothy W Meyer; Fiscal Year: 2010
    ..investigators have identified large differences in indican and p-cresol sulfate production in patients on peritoneal dialysis and patients on hemodialysis...
  13. Cascading Impacts of Bundled Payment on Peritoneal Dialysis Provision &Outcomes
    Virginia Wang; Fiscal Year: 2013
    DESCRIPTION (provided by applicant): Despite the appeal of peritoneal dialysis (PD) to patients, physicians, and providers, there is limited understanding of the mechanisms behind PD's low and diminishing utilization in the US...
  14. COATING OF URINARY PROTHESES TO PREVENT ENCRUSTATION
    Harmeet Sidhu; Fiscal Year: 2000
    ..catheters are frequently used in urological and nephrological medicine for the management of urinary and peritoneal dialysis flow, haemodialysis, and drainage of renal calculi following laser or lithotripsy treatment...
  15. 14th International Conference on Dialysis Advances in CKD 2012
    Mary Carter; Fiscal Year: 2012
    ..Nephrology (ISN), the International Pediatric Nephrology Association (IPNA), the International Society of Peritoneal Dialysis (ISPD), the National Kidney Foundation (NKF) the Sustainable Kidney Care Foundation (SKCF) and the Renal ..
  16. Dynamics of Peritoneal Dialysis Associated Peritonitis
    John Hotchkiss; Fiscal Year: 2004
    ..on interactions between dynamics of bacterial growth and optimal bacterial clearance in the setting of peritoneal dialysis associated peritonitis (PDAP)...
  17. Stent Lock Mechanism for Transcutaneous Catheters
    NICHOLAS VITALE; Fiscal Year: 2005
    b>Peritoneal dialysis, intravascular access for chemotherapy, transcutaneous intrathoracic access of cardiac power lines, and suprapubic bladder drainage are among the clinical applications where transcutaneous catheters are routinely used ..
  18. IN VIVO STUDY OF INTERSTITIAL CONVECTION
    MICHAEL FLESSNER; Fiscal Year: 1999
    ..homeostasis but also of major importance in therapeutic procedures such as macromolecular drug delivery or peritoneal dialysis. Recently proposed mathematical models of interstitial fluid and protein transport include theories of ..
  19. ADHERENCE AND ADJUSTMENT IN END-STAGE RENAL DISEASE
    Alan Christensen; Fiscal Year: 2003
    ..g., continuous ambulatory peritoneal dialysis) but poorer adherence when receiving staff administered dialysis (e.g., center hemodialysis)...
  20. Assessing Functional Outcomes in Adolescent with ESRD
    Susan Furth; Fiscal Year: 2002
    ..quality of life (HRQL) for pediatric patients with chronic renal failure or ESRD treated with hemodialysis, peritoneal dialysis or transplant. Resources provided by the RO3 award will allow Dr...
  21. Commercialization of Human Omental Mesothelial Cells for Research
    YOLANDA LEA CURRIE; Fiscal Year: 2007
    ..DESCRIPTION (provided by applicant): Mesothelial cells have been found to be pivotal in tumor metastasis, peritoneal dialysis, and inflammatory response...
  22. S.T.R.A.P Sonos Transportable Renal Application Product
    Martin Roberts; Fiscal Year: 2005
    ..5 billion. Hemodialysis requires patient treatment 3 times a week for 3-4 hours. Peritoneal dialysis is an option utilized by less than 10% of patients requiring manual exchange of 2 liters of dialysate every ..
  23. Commercialization of Human Mesothelial Cells for Research
    YOLANDA RENEE LEA CURRIE; Fiscal Year: 2010
    Mesothelial cells have been found to be pivotal in tumor metastasis, peritoneal dialysis, and inflammatory response...
  24. DIURNAL AND PULSATILE PTH SECRETION IN RENAL FAILURE
    William Goodman; Fiscal Year: 2001
    ..with secondary hyperparathyroidism will also be evaluated, and the respective roles of hemodialysis and peritoneal dialysis as separate modifiers of diurnal and pulsatile PTH secretion in end-stage renal disease will be examined...
  25. Comorbidity, Costs and Outcomes in Dialysis Patients
    Srinivasan Beddhu; Fiscal Year: 2002
    ..Prior studies showed patients with high comorbidity have higher peritoneal dialysis technique failure...
  26. PRODUCTION OF STERILE WATER FOR INJECTION ON DEMAND
    Edit Hegyi; Fiscal Year: 2001
    ..of sterile online mixing technology it will provide sterile replacement fluids and sterile dialyzate for peritoneal dialysis and continuous renal replacement therapy...
  27. Dietary Adherence Enhancement in Peritoneal Dialysis
    MARY SEVICK; Fiscal Year: 2007
    ..study will pilot test an intervention! based on self-efficacy theory, to improve adherence to the peritoneal dialysis dietary regimen...
  28. Patient-Oriented Research in Kidney Disease
    Neil Powe; Fiscal Year: 2009
    ..This is a national prospective cohort study comparing treatment and outcomes in hemodialysis and peritoneal dialysis patients...
  29. LONG-TERM PERCUTANEOUS ACCESS DEVICE FOR HOME THERAPIES
    Paul Freed; Fiscal Year: 1999
    ..that require long- term body access, such as total parenteral nutrition, drug delivery, ambulatory peritoneal dialysis, and heart assist devices...
  30. LONG-TERM PERCUTANEOUS ACCESS DEVICE FOR HOME THERAPIES
    LUDMILA BERNSTAM; Fiscal Year: 2005
    ..devices for treatment of chronic heart failure, total parenteral nutrition, drug delivery, and ambulatory peritoneal dialysis. The PAD is pre-seeded with autologous fibroblasts derived from a small sample of the recipient's skin...
  31. PATIENT ADHERENCE AND ADJUSTMENT IN RENAL DIALYSIS
    Alan Christensen; Fiscal Year: 1999
    ..e., continuous ambulatory peritoneal dialysis-- CAPD) but poorer adherence when receiving staff-administered dialysis (i.e., center hemodialysis)...
  32. Colorimetric Breathalyzer for Dialysis Monitoring
    WILLIAM MCNAMARA; Fiscal Year: 2002
    ..of great value in determining the dialysis state of both patients undergoing hemodialysis in a clinic and peritoneal dialysis at home. ChemSensing, Inc...
  33. GENETIC SUSCEPTIBILITY TO END STAGE RENAL DISEASE
    Sudha Iyengar; Fiscal Year: 2002
    ..for ESRD (but concordant for Type 2 diabetes mellitus) and 200 additional family members from hemodialysis, peritoneal dialysis and transplant centers as part of a study to identify genetic risk factors for ESRD...
  34. CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)
    Dimitrios Oreopoulos; Fiscal Year: 1980
    A new type of dialytic therapy - Continuous Ambulatory Peritoneal Dialysis (CAPD) - originally pioneered by NIH supported research in the United States has recently been significantly improved by Dr...
  35. SURFACE MODIFICATION FOR IMPROVED PERCUTANEOUS CATHETERS
    DAVID CLAPPER; Fiscal Year: 1991
    This project is designed to improve continuous ambulatory peritoneal dialysis (CAPD) catheters by developing an improved exit port that will produce a stable integument seal and greatly reduce the frequency of catheter sepsis...
  36. ON LINE PRODUCTION OF ULTRAPURE WATER FOR DIALYSIS
    Peter Grandics; Fiscal Year: 1999
    ..This technology has broader range of applications that we have outlined, including peritoneal dialysis, home hemodialysis, production of WFI grade solutions in hospitals, pharmacies, and pharmaceutical ..
  37. MMHD CLINICAL CENTER
    Michael Rocco; Fiscal Year: 2001
    ..The staff at these dialysis centers have participated in both hemodialysis and peritoneal dialysis clinical research protocols...
  38. PROCESS, OUTCOME AND QUALITY OF CARE IN ESRD
    Neil Powe; Fiscal Year: 2004
    ..The purpose of the project now shifts from comparing outcomes between hemodialysis and peritoneal dialysis patients (the aim of the original project) to studying of the relation between a variety of process ..
  39. Improved Catheter System for Dialysis
    Vinayak Kini; Fiscal Year: 2003
    One aim of this project is to develop a protocol to optimize the design of peritoneal dialysis catheter systems for use in the treatment of end-stage renal disease...
  40. Effects of Hyaluronan on Interstitial Convection
    MICHAEL FLESSNER; Fiscal Year: 2007
    ..to quantify solute diffusion and convection in the subperitoneal muscle of anesthetized rats during peritoneal dialysis. The in vivo model permits control of the tissue pressure forces and measurement of the pressure profile ..
  41. PERITONEAL DELIVERY OF ANTINEOPLASTIC MACROMOLECULES
    MICHAEL FLESSNER; Fiscal Year: 2004
    ..of the MAb to tumor, a human xenograft will be transplanted into the abdominal wall of athymic rats, and peritoneal dialysis will be used to deliver MAb. The tumor position permits control of the intraperitoneal (i.p...
  42. Functional Health CAT in Chronic Kidney Disease
    JOHN WARE; Fiscal Year: 2002
    ..Disease instruments will be calibrated on a common metric for each HRQOL domain to specifically address peritoneal dialysis. CKD-CAT will be evaluated (reliability, validity and precision) to create a fully operational system that ..
  43. ENZYME IMMOBILIZATION FOR REMOVAL OF TOXIC METABOLITES
    PATRICK GUIRE; Fiscal Year: 1991
    ..such as diet manipulation, gene replacement therapy, chemotherapy, transfusions, transplantations, and peritoneal dialysis have produced marginal improvements in these patients...
  44. Antimicrobial Dendrimers for Catheter Utilization
    HANS GLAESER; Fiscal Year: 2001
    ..Phase I focus will be on central venous catheters with peritoneal dialysis catheters being evaluated at a later time...
  45. Poloxamer-188 for the prevention of fibrosis during peritoneal dialysis
    BRUCE MARKHAM; Fiscal Year: 2008
    ..unreadable] [unreadable] This application is focused on preventing adverse events associated with chronic peritoneal dialysis (PD), a renal replacement therapy for end stage renal disease (ESRD)...
  46. MethLock vs. heparin as dialysis catheter lock
    Stephen Ash; Fiscal Year: 2008
    ..In Phase II we will implement the protocol in a number of dialysis centers and complete the study as originally proposed or as modified after Phase I. ..
  47. Pheresis Treatment of Bioterrorism-Induced Sepsis
    Stephen Ash; Fiscal Year: 2005
    ..The safety systems of the existing PF system will be modified to meet the needs of the stand-alone system. Finally, an animal model of sepsis will be used to check efficacy and safety of the entire system. ..
  48. Nutritional/Inflammatory Evaluation of Dialysis Patients
    Kamyar Kalantar Zadeh; Fiscal Year: 2005
    ....
  49. Anti-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients
    Kamyar Kalantar Zadeh; Fiscal Year: 2008
    ..unreadable] [unreadable] [unreadable]..
  50. ROLE OF PARATHYROID HORMONE IN RENAL OSTEODYSTROPHY
    Isidro B Salusky; Fiscal Year: 2009
    ..The results of the study should provide new information on the relationship between PTH and bone formation in CKD and they are likely to have important implications for the diagnosis and treatment of renal osteodystrophy. ..
  51. Cardiovascular Disease and Diabetic Nephropathy
    Rajnish Mehrotra; Fiscal Year: 2008
    ..The applicant has institutional support and a career development plan including obtaining a Masters in Clinical Investigation, to achieve his career goals. ..